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Abstract: Acceptance and Commitment Therapy (ACT) has accrued a substantial evidence 
base. Recent systematic and meta-analytic reviews suggest that ACT is effective compared to 
control conditions. However, these reviews appraise the efficacy of ACT across a broad range 
of presenting problems, rather than addressing specific common mental health difficulties.  
Focussing on depression and anxiety we performed a meta-analysis of trials of ACT. We 
incorporated sequential meta-analysis (SMA) techniques to critically appraise the sufficiency 
of the existing evidence base. Findings suggest that ACT demonstrates at least moderate 
group and pre-post effects for symptom reductions for both anxiety and depression. 
However using SMA findings are more qualified.  There is currently insufficient evidence to 
confidently conclude that ACT for anxiety is efficacious when compared to active control 
conditions or as primary treatment for anxiety. Similarly, using SMA, there is currently 
insufficient evidence to suggest a moderate efficacy of ACT for depression compared to 
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active control conditions. To stimulate further research we offer specific estimates of 
additional numbers of participants required to reach sufficiency to help inform future 
studies. We also discuss the appropriate strategies for future research into ACT for anxiety 
given the current evidence suggests no differential efficacy of ACT in the treatment of anxiety 
compared to active control conditions.  
 
Keywords: sequential meta-analysis, acceptance and commitment therapy, mental health, 
treatment efficacy, anxiety, depression 
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1. Introduction 
Within the last decade third wave treatment approaches (Hayes, 2004) have widened the 
spectrum of evidence-based psychological treatments, particularly in relation to mental 
health conditions deemed longstanding, complex or treatment resistant. ‘Third wave’ 
therapies have gained currency as an alternative to more established models of cognitive 
behavioural therapy (CBT) (e.g. Beck, 1963) via a relatively greater emphasis on context and 
experiential facets of psychological experience.  
Third wave cognitive behavioural therapies include among others Dialectical Behavioural 
Therapy (DBT, Linehan, 1995), Mindfulness Based Cognitive Therapy (Segal, Williams, & 
Teasdale, 2012), Compassion Focused Therapy (Gilbert, 2004), and Acceptance and 
Commitment Therapy (ACT, Hayes, Strosahl, & Wilson, 1999). The third wave therapies also 
make explicit attempts to balance a coherent theoretical underpinning with a commitment to 
empirical testing.  
Controlled trials have suggested efficacy for ACT in the treatment of depression, mixed 
depression and anxiety, physical health problems and psychotic disorders. Meta-analyses of 
randomized controlled trials of ACT have suggested a moderate to large effect size on 
primary outcomes measures after treatment and at follow-up (Hayes, Luoma, Bond, Masuda, 
Lillis, 2006; Ost, 2008; Powers, Zum Vorde Sive Vording, & Emmelkamp, 2009, Ruiz, 2010, 
2012). A recent meta-analysis of ACT by Ruiz (2012) concluded that ACT outperformed CBT 
(Hedges g = 0.4). However, the debate regarding the differential efficacy of ACT compared to 
other evidence-based psychological interventions is ongoing  (e.g. Hoffman & Asmundsen, 
2008, 2010; Ost, 2009). The proliferation of third wave approaches raises questions for 
clinicians and policy makers (and clients/service users) regarding which therapeutic 
intervention is of optimal benefit for a given disorder or difficulty. This is especially 
important to the development of clear guidelines for the evidence-based practice of 
psychological interventions.  
Existing evidence from systematic and meta-analytic reviews provide qualified support for 
the effectiveness of ACT as a psychological intervention when compared with no 
intervention (Ruiz, 2012; Powers et al., 2009). However, the data with regards to ACT in 
comparison to other psychological therapies are more equivocal. Therefore, clinicians, health 
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service commissioners and policy makers at present must judge whether the evidence base 
for ACT is sufficient to make a confident recommendation regarding its efficacy. Borrowing 
from public health research (Muellerleile & Mullen, 2006; Wetterslev, Thorlund, & Gluud, 
2008), a novel statistical approach to this question is the appraisal of the sufficiency of the 
available cumulative knowledge. Where the total cumulative knowledge is still emerging, 
meta-analytic findings are at risk of false positives or false negatives due to methodological 
weaknesses such as power, random errors or systematic error (e.g. Kuppens, Heyvaert, Van 
den Noortgate, & Onghena, 2011). Sequential meta-analysis (SMA; Pogue & Yusuf, 1997) uses 
group sequential boundaries based on the alpha spending function to measure the 
accumulation of knowledge across studies, enabling decisions on the sufficiency of 
knowledge to recommend treatment to be made based on statistical properties. This 
approach, commonly used in the evaluation of medical interventions (e.g. Devereaux, Beattie, 
Choi, Badner, Guyatt, Villar et al. 2005; Wetterslev et al., 2008) is under-utilized in the 
evaluation of psychological therapies. Although of potential benefit to evaluation of all 
evidence based psychological therapies we choose in this review to focus on ACT as an 
example of an emerging psychological therapy with a commitment to evidence-based 
practice.  
In view of the above, our primary aim was to quantitatively review outcomes of ACT 
interventions for anxiety and depression using two complementary statistical approaches. 
Firstly, using cumulative meta-analytic techniques (CMA), we reviewed the evidence for ACT 
as a psychological intervention for anxiety and depression in group and pre-post 
comparisons. Secondly, we reviewed the evidence for the same conditions using sequential 
meta-analytic techniques (SMA). Use of SMA enabled us to make an estimate of the 
sufficiency of the evidence base for ACT. Secondary aims were to investigate the efficacy of 
ACT when compared against active treatments and when anxiety or depression were 
predetermined target outcomes. Regarding the primary aims we hypothesise that there is 
sufficient evidence to suggest that ACT is efficacious in the treatment of anxiety and 
depression. With regards to SMAs, to the best of our knowledge, this is the first time that a 
sequential meta-analytic approach has been used to appraise the sufficiency of evidence of 
ACT. Therefore no specific hypotheses were made.  
2. Method 
Our quantitative review followed two stages. Firstly the literature was systematically 
searched to identify the study sample and to extract data. Secondly, the data was analysed 
using meta-analytic techniques. This stage incorporated conventional cumulative meta-
analyses for ACT for anxiety or depression in group and pre-post comparisons, sequential 
meta-analyses for these conditions and lastly, subgroup analyses in which ACT was 
compared with active treatments and in conditions were anxiety or depression were 
predetermined treatment outcomes.  
2.1 Literature search 
2.1.1 Eligibility criteria 
A systematic literature search was conducted to identify potential studies, following PRISMA 
guidelines (Moher, Schulz, & Altman, 2008). Studies were included if they (1) investigated a 
manualised ACT approach, (2) used a randomised control design, (3) assessed anxiety or 
depressive symptoms using standardised outcome measures.   
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Studies were excluded if they (1) were not published in English, (2) did not include a 
standardised measure of anxiety or depression, (3) did not use an RCT methodology, or 4) 
were not published in a peer-reviewed publication, e.g. conference abstracts, book chapters, 
dissertations. 
2.1.2 Information sources 
Studies were identified by searching several database namely: PsycINFO 1840 to June 2015, 
MEDLINE 1966 to June 2015, SCOPUS 1841 to June 2013, Cochrane Central Register of 
Controlled Trials for 2014. 
2.1.3 Search 
We used search terms incorporating conjunctions of therapy and trial design terms: 
‘acceptance and commitment therapy’ or ‘acceptance’, ‘random’, ‘randomly’, ‘randomise’, 
‘randomize’, ‘randomised’, ‘randomized’, ‘clinical trial’, or ‘trial’. These words were searched 
as key words, title, abstract, and MeSH subject heading terms. Also, we examined citation 
maps and used the ‘cited by’ search tools. Limits were then implemented to further refine the 
scope and ensure quality: databases were de-duplicated; searches limited to peer-reviewed 
articles; searches limited to human studies; and searches limited to adult studies. Reference 
lists of all relevant articles and existing systematic reviews (e.g. Powers et al., 2009) were 
screened by the authors to ensure no studies were overlooked. 
2.1.4 Data collection  
The data was extracted into an electronic data extraction sheet by the first author and 
independently reviewed by the second author. Information extracted from the studies 
included (1) trial characteristics (including first author, publication year, and participant 
number), (2) control group characteristics (including active or non-active control), and (3) 
outcome characteristics (outcome measures). 
2.1.5 Risk of bias measurement 
To minimise the risk of data selection biases we included data pertaining to all reported 
anxiety and depression outcomes.  
2.1.6 Summary measures  
Standardised mean differences with heteroscedastic population variances (SMDH) for 
independent groups and for dependent groups were calculated (Bonett, 2008, 2009). 
Additionally, considering the small study samples Knapp and Hartung’s adjustments (Knapp 
& Hartung, 2003) were calculated, yielding closer to nominal standard errors of the 
estimated parameters. 
2.1.7 Study selection  
Inclusion, exclusion criteria and search terms were specified a-priori.  
The literature search identified initially 1865 studies. Study titles and abstract were 
screened against inclusion and exclusion criteria. Two independent reviewers conducted 
screening (first and second authors). Studies were assessed by considering the eligibility by 
the second author and revised by the first author. Disagreement was resolved through 
discussion.  
In cases where insufficient data was reported in the primary study to apply meta-analytic 
methods we attempted to retrieve additional information from the first author of the 
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published paper. Five authors were contacted to retrieve additional information. One author 
provided additional information. The review flowchart is illustrated in Fig. 1. 
[Insert Fig. 1 about here] 
Quality assessments of the studies were evaluated using the 34-item Consort 2010 checklist 
(Moher et al., 2010). Each item is rated on a 3-point scale from 0 to 1, where 0 = absent, 0.5= 
partial, 1= complete. Overall, Consort checklist scores range from 0 to 34. Higher overall 
scores suggest superior methodological rigour. The second and third author independently 
assessed a randomized subset of 10 % of studies to check for inter-rater reliability. All 
studies were randomised using www.random.org list randomizer. Where there were 
ambiguities between the reviewers, the studies were jointly reviewed to reach a unanimous 
decision. If further ambiguities remained a third reviewer had the ultimate decision. All 
remaining studies were randomised and divided amongst the two reviewers for independent 
evaluation. Overall the inter reviewer concordance was Kappa = 0.85, suggesting an excellent 
agreement (Banerjee, Capozzoli, McSweeney, & Sinha, 1999). 
2.2 Literature appraisal 
2.2.1 Meta-analytic approach 
All meta-analytic procedures were conducted using the R-software package ‘metafor’ 
(Viechtbauer, 2015). Conducting consecutive meta-analyses that incorporate the same or 
virtually the same study sample can significant increase the risk of both type I and type II 
errors (Higgins, Thompson, Deeks, & Altman, 2008; Borm & Donders, 2009). Findings may be 
erroneously deemed positive when they may be due to chance findings or false-positives. 
Similarly, findings might be rejected as negative or neutral due to lack of precisions or 
statistical power. A sequential meta-analysis method offers a statistical approach to manage 
these risks (Wald 1947; Pogue and Yusuf, 1997).  
In this analysis we used a four-steps analytic approach described by Kuppens and Onghena 
(2012) including the calculation of the optimal information size, conducting cumulative 
meta-analyses, constructing sequential boundaries, and determining statistical sufficiency.  
These steps will be described in detail in the ensuing sections.  
Computing optimal information size (OIS) 
Arguably the level of convincing evidence for a meta-analysis should be no less than that of a 
well-designed single trial. To determine the threshold level of sufficiency Pogue and Yusuf 
(1997) proposed that conventional sample size calculation methods can be used. The optimal 
information size (OIS) is the sample size required to detect a presumed pooled effect whilst 
minimising type I and II errors. However, this approach does not control for heterogeneity 
between studies when using meta-analytic methods. Therefore a heterogeneity adjusted 
method for hierarchical designs can be used to control for the degree of between study 
variability (Higgins, Whitehead, & Simmonds, 2010; Kuppens & Onghena, 2012). The 
heterogeneity adjusted OIS (HOIS) can be readily calculated as follows:  
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Conventionally, the I2 index measures the extent of true heterogeneity dividing the 
difference between the Q value and its degrees of freedom (k-1) by the Q value, and 
multiplied by 100 (Borenstein, 2009). To render authorities conclusions regarding the 
evidence base for ACT we chose more stringent criteria for alpha, power and proposed effect 
sizes (α=.01, 1-β=.9) as recommended by Kuppens and Onghena (2012). Considering the 
moderate to high heterogeneity reported in previous meta-analyses (Ruiz, 2012) the authors 
also elected to use a high heterogeneity estimate (e.g. I2=75%) in their HOIS calculations. 
Lastly, considering currently reported effect size estimates a medium effect size (e.g. d=.5) 
was selected to be a reasonable estimate for the HOIS calculations. We used the open-source 
program G*Power 3 (Faul, Erdfelder, Lang, & Buchner, 2007) to calculate heterogeneity 
adjusted OIS’s (Table 3). 
Cumulative meta-analysis  
To obtain pooled cumulative estimates of effect sizes over time cumulative meta-analyses 
were conducted on a chronologically ordered study sample (e.g. publication year). Random 
models were used to calculate pool effect sizes at interim analysis points.  
Independent meta-analyses were conducted for anxiety and depression in order to conform 
to the assumption of independent effect sizes that underline meta-analytic procedures 
(Borenstein, 2009). When several relevant outcome measures were reported, the outcomes 
yielding the most conservative effect size estimate per study were included in the analyses. 
Sequential boundaries 
The optimal information size can be used to calculate the group sequential boundaries b 
using the alpha-spending function by Lan and DeMets (1983). This function    is a 
monotonically non-decreasing function which allocated the allowable Type I error through a 
function based on the information fraction t. The information fraction t in turn is the 
proportion of (heterogeneity adjusted) optimal information size (HOIS) that has been 
accumulate at a particular interim analysis point q thus          ⁄ . Several functions can 
be fitted into the Lan and DeMets (1983) alpha spending function including the O’Brien 
Fleming used in this analysis (Reboussin, DeMets, & Lan, 2000): 
  
      
{
 
 
     
 (   (
  
 ⁄
√ 
⁄ ))       
 
 
  is the standard nomal distribution function. The function thus allows for the calculation of 
sequential boundaries   . This statistic corresponds to the critical Z-value for the allocated   
at each step of the interim analysis.  
Sufficiency 
At each interim point of the analysis q we obtain two standardized test statistics    and    
that denote the Z values of the pooled effect size and allocated   respectively. Sufficiency is 
determined by comparing the    and   scores at each step of the interim analysis. As long as 
⌈  ⌉     sufficiency has not yet been attained and further studies are needed. However, if 
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the criterion of ⌈  ⌉     is reached at an interim point of the analysis sufficiency of 
evidence indicates that a predetermined treatment effect exists. In turn, if the optimal 
information size has been reached and ⌈  ⌉    , sufficiency of cumulative evidence is 
achieved to refute the effectiveness of the intervention in relation to the predetermined 
effect size,   and power.  
3. Results 
3.1 Literature search 
The systematic literature search identified k=28 and k=39 eligible randomized controlled 
trials studies of ACT for anxiety and depression respectively. Study characteristics including 
trial characteristics, control group characteristics, and outcomes are described in Table 1-3.  
[Insert Tables 1 - 3 about here] 
The total participant sample in this quantitative review was n=1628 and n=1987 
participants in anxiety and depression trials. The sample size for participants within both 
anxiety and depression treatment trials varied from n=6 to n=125 per group. All papers were 
published between 1989 and 2015. Within the reviewed sample the modus of published 
trials for anxiety treatment were in 2011, 2013 and 2014 (k=8). In turn, for depression the 
modus of published depression treatment trials was in 2011 and 2012 (k=8). For both 
anxiety and depression outcomes the majority of trials compared ACT against a waiting list 
control (WL; k=17 and k=22 studies for anxiety and depression respectively). The majority of 
anxiety treatment trials used CBT as bona fide treatment comparator (k=7). Similarly, the 
most frequent bona fide control treatment condition in depression treatment trials was CBT 
(k=9). The most frequently used anxiety outcome measure was the Depression Anxiety and 
Stress Scale (DASS-A, k=9). In turn, the most frequently used depression outcome measure 
was the Beck Depression Inventory (BDI, k=18). Less than a third of anxiety trials (k=10) 
employed an active control condition compared to 38% of depression trials (k=15). Eighteen 
per cent of anxiety trials (k=5) and 31% of depression trials (k=12) predetermined the 
primary target outcome.  
3.2 Literature appraisal  
3.2.1 Optimal information size (OIS) 
The calculated heterogeneity adjusted optimal information size was n=220 and n=848 for 
pre-post and group comparisons respectively.  
3.2.2 Cumulative meta-analyses 
A series of random-effects cumulative meta-analyses were conducted. Findings are listed in 
Table 4. Regarding the primary aims the cumulative meta-analysis yielded large significant 
effects for pre-post treatment reduction in anxiety (d= .95, p<.001) and depression (d=.92, 
p<.001) scores. Analyses also revealed a small significant effect for group treatment changes 
for anxiety (d= .45, p<.05) and a medium effect size for depression (d=.54, p<.001) favouring 
ACT.  
[Insert Table 3 about here] 
Regarding the secondary aims, for ACT for anxiety the pre-post comparison suggested a large 
significant effect (d=1.85, p<.01) when anxiety was predetermined as primary treatment 
 8 
target. In turn, ACT for anxiety in active control conditions revealed no effect (d= -.04, n.s.). 
Similarly, findings for ACT for anxiety in group comparisons when anxiety was the primary 
treatment target revealed a non-significant large effect (d= .77, n.s.). In pre-post comparisons 
for ACT where depression was the primary treatment target findings suggested a large 
significant effect (d= 1.22, p<.001). Group comparisons for ACT for depression as a primary 
treatment target suggested also large significant effects (d= .73, p<.001).   In group 
comparisons for ACT versus an active control conditions findings suggested a small non 
significant effect (d=.26, n.s.)  
3.2.3 Sequential meta-analyses 
In relation to sufficiency, findings will initially be described for ACT in both pre-post and 
group comparisons for the whole study sample. We will then continue to describe findings 
comparing ACT when anxiety or depression was specified a-priori as target outcome and 
against active control conditions. Lastly, findings from auxiliary analyses will be described.   
As illustrated in (Figs 2a,c,d), sufficiency was reached for all SMAs for anxiety and depression 
with the exception of ACT for anxiety in group comparisons (Fig. 2b). In this comparison, 
although statistical sufficiency (HOIS) was reached, the threshold boundary was not crossed 
thus based on these data it cannot be assumed that ACT is  moderately effective in treatment 
of anxiety in group comparisons. It is of note that for ACT for depression in pre-post 
comparisons, the intermittent Z-value crossed the threshold boundary at some point in the 
analysis (Fig. 2c). However, at the end point when the accumulated alpha has been reached 
(i.e. t≥1), the sequential boundary was not crossed (Zα=.01=2.46, Zt≥=1=2.17).  Although at the 
end point of the analysis the sequential boundary has not been crossed, nonetheless 
statistical criterion for ACT as an efficacious intervention has been met.   
Our analyses suggest that ACT for anxiety as an a-priori comparator in pre-post comparisons 
is at least moderately effective as the threshold boundary was crossed at some point in the 
analysis (Fig. 3a). In contrast, findings from the SMAs of ACT for anxiety in group 
comparisons when a-priori determined as treatment or when compared with active control 
conditions, suggest that there is currently insufficient evidence to indicate a medium effect 
(Fig. 3b & 3c).  . As described in Table 3 additional samples of n=573 and n=290 participants 
respectively would be required to reach the predetermined heterogeneity adjusted optimal 
information size for group comparisons when anxiety has been predetermined or compared 
to an active control condition.  
In relation to ACT for depression findings suggest that there is sufficient evidence of a least a 
medium effect in studies where depression was a-priori specified as a target outcome.  This 
is the case for both pre-post and group comparisons (Fig. 4a & 4b),. Conversely, our findings 
suggest that ACT for depression in group comparisons with active control conditions there is 
currently insufficient evidence to indicate a medium effect as sufficiency (HOIS) has been 
reached (HOIS) (Fig. 4c). An additional samples of n=93 would be required to reach the 
predetermined heterogeneity adjusted optimal information size for group comparisons with 
active controls in depression. 
3.2.4 Auxiliary analyses 
To further explore the differential efficacy of ACT and CBT we conducted additional post-hoc 
meta-analyses. For anxiety findings from a cumulative meta analysis (k=8) suggest that there 
is currently no differential effect between these two treatment modalities (d=.08, n.s.). An 
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additional n=260 participants would be required to be able to determine the sufficiency of 
cumulative evidence.  
Similarly the cumulative evidence (k=10) of ACT for depression revealed no differential 
effect between ACT and CBT (d=-.01, n.s.). An additional n=314 participants would be 
required to be able to confidently appraise the statistical sufficiency of the cumulative 
evidence.  
 
3.2.5 Publication Bias Analysis 
As we did not include unpublished work in our meta-analyses we tested for publication bias 
in the following ways. Firstly, funnel plots were examined. demonstrating no systematic 
publication biases (tables available from first author on request). Secondly..Fail-safe N 
(Rosenthal, 1979) values ranged from k=2048 to k=6708 studies for the primary study aims, 
suggesting absence of publication bias. For the secondary study aims Fail-safe N values 
ranged from k=288 to k=671 studies, again suggesting absence of publication bias.  
4. Discussion 
The aim of this paper was to quantitatively review the cumulative evidence for ACT as a 
treatment for anxiety and depression. In doing so we generate sample size estimates for ACT 
trials in which there is currently insufficient evidence to determine the sufficiency of the 
evidence for ACT. Our novel statistical approach enables us to confidently appraise the 
treatment literature from a standpoint of statistical sufficiency. In contrast to conventional 
meta-analysis our approach controls for typical threats to statistical techniques in the 
evaluation of evidence based psychological therapies e.g. type I and II statistical errors; and 
between-sample heterogeneity – thereby enhancing the statistical basis for determining 
treatment sufficiency.  
In total we included k=28 and k=439 studies for anxiety and depression respectively. The 
cumulative pooled effect sizes for ACT for anxiety for both pre-post and group comparisons 
ranged from d= .45 to d=.95. In turn, the cumulative pooled effect sizes for depression in 
trials comparing ACT in pre-post and group comparisons ranged from d= .54 to d=.92. Our 
findings suggest that there is currently cumulative evidence for the efficacy of ACT versus 
controls in the treatment of anxiety and depression. All four cumulative meta-analyses for 
anxiety and depression were statistically significant. Equally findings from SMAs suggested 
sufficiency of evidence of an at least moderate effect for these conditions with the exception 
of ACT for anxiety in group comparisons. Thus one can conclude that with respect to the 
efficacy of ACT versus control conditions statistical sufficiency is reached and no further 
randomized clinical trials are required. Findings are thus in keeping with the previous 
literature for the overall cumulative efficacy of ACT (e.g. Hayes, Luoma, Bond, Masuda, Lillis, 
2006; Ost, 2008; Powers et al., 2009; Ruiz, 2010, 2012). However, applying an SMA approach 
suggests that although sufficiency has been reached in terms of clinical trials (as exemplified 
by above-threshold HOIS values), we conclude that the effect size of ACT for anxiety in-group 
comparisons is below a moderate effect. 
However, findings are more qualified when considering the evidence for ACT compared to 
active control conditions i.e. existing evidence-based therapies, and when anxiety or 
depression were the primary treatment targets. For anxiety, although cumulative evidence 
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suggest a strong significant effect in pre-post comparisons (d=1.85, p<.001) other cumulative 
meta-analyses for ACT for anxiety were not significant. Similarly, SMAs of ACT for anxiety for 
group comparisons failed to reach sufficiency (Figs 3b&c). There is currently insufficient 
evidence to confidently infer a moderate effect between these intervention conditions (Fig. 
3). However ACT for anxiety in pre-post comparisons, where ACT has been specified a-priori 
as the primary outcome, there is sufficient evidence to infer that ACT has a moderate effect. 
With respect to the analyses that fail to reach sufficiency two factors might account for these 
findings. Firstly, these SMAs for anxiety were underpowered; thus findings may have been 
erroneous. Secondly, Z values for the cumulative evidence suggest that, although HOIS has 
not yet been reached, there is no differential benefit for ACT in group conditions when ACT 
was predetermined as a treatment outcome or when compared to an active control (Zactive=-
.46; Fig. 3c). Equally, there is little differential benefit for ACT for anxiety in group 
comparisons when primarily targeting symptoms (Zgroup, primary=1.22; Fig. 3b). Findings 
therefore seem to indicate similar outcomes are obtained irrespective of the active 
intervention. It is thus not likely to assume that additional clinical trials will reveal 
differential efficacy. These findings may inform treatment planning in settings or healthcare 
structures where estimates of differential efficacy are practically relevant to operationalizing 
treatment programmes. 
Conversely, where ACT for depression was the primary outcome the cumulative evidence 
suggest large significant effects in both group-(dgroup, primary =.73, p<.01) and pre-post 
comparisons (dpre-post, primary=1.22, p<.001). Findings from SMAs for these comparisons also 
suggests that sufficient evidence exists to indicate an at least medium effect (Fig. 4a & 4b). 
However, cumulative evidence of ACT for depression against active controls suggests a small 
non significant effect (dgroup, active=.26, n.s.). However. the SMA for this comparison (Fig. 4c) 
failed to reach statistical sufficiency.  Consequently, the same issues raised above with regard 
to the anxiety comparisons that failed to reach sufficiency also apply to the effect of Act for 
depression when compared against normal controls. 
It is noteworthy that careful consideration should be given whether and how additional 
randomized control trials meaningfully add to the existing knowledge base. For example in 
our study, when appraising the effect size of ACT for anxiety in active control conditions (i.e. 
d=-.04, n.s.), a difference in treatment gains might not become readily apparent. A possible 
explanation for this may be that ACT and CBT share therapeutic techniques, particularly 
exposure strategies. 
Overall, the findings suggest that ACT is effective in the treatment of common mental health 
difficulties; however not more so than traditional treatment approaches. For instance, within 
the theoretical literature on ACT there has been discussion of the treatment mechanisms by 
which ACT leads to change in clinical presentations e.g. psychological flexibility. Our analysis 
does not evaluate these questions of process. Therefore, it may be a productive line of 
enquiry for future studies of ACT to emphasise the unique components of the intervention 
that may generate change in particular presentations (Arch & Craske, 2008). From this 
perspective, future research might thus attempt to answer questions of optimising treatment 
matching i.e. ‘what works for whom’ (Roth & Fonagy, 2006).   
We acknowledge that the review is subject to several caveats. Efforts were made to retrieve 
grey literature in relation to ACT RCTs to minimise the impact of publication biases. Results 
of the analyses indicate no significant file drawer effect, thus publication errors are not likely 
to have significantly biased our results.  
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The heterogeneity indexes suggest a significant level of between study variance in the 
sample. Therefore it could be argued that the study sample is too diverse to meaningfully 
infer general conclusions regarding the evidence base as a significant proportion of between 
study variance has not been explained. However, our findings are in keeping with previous 
quantitative reviews and as such offer additional support for the veracity of our findings. In 
addition, the observed heterogeneity may be considered an accurate reflection of the scope 
of the application of ACT and as such might be suggestive of the external validity of our 
findings. We also acknowledge that our study set out to explore the efficacy of ACT for 
anxiety and depression. Consequently, the current analyses cannot comment on the efficacy 
of ACT for other complex mental health conditions e.g. psychosis (White et al., 2013) or 
physical health conditions such as chronic pain (McCracken, Sato, & Taylor, 2013).  
The use of SMA has introduced discussion around the use stop criteria in research 
considerations (Higgins et al., 2010; Pogue & Yusuf, 1997). As noted our intention in using 
the method has been to inform future research. Although historically SMA has been used to 
inform decision on research funding in clinical trials (Wetterslev et al., 2008) we caution 
against the indiscriminate application of SMA for such sole purpose. Whether or not 
individual trials proceed is a complex decision making process of which sufficiency 
considerations might comprise one aspect of multiple evidence strands, e.g. in conjunction 
with Disability Adjusted Life Years (DALYs).  
Lastly, it is important to note that symptom reduction is not the primary intervention 
objective of ACT interventions; instead ACT aims to improve psychological flexibility (Harris 
& Hayes, 2009; Hayes et al., 2011). Future studies might want to investigate other outcome 
domains consistent such as function or quality of life which may be more germane to third 
wave interventions.   
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Figure 1: Flow diagram of the study selection process. 
Figure 2: Sequential meta-analyses of ACT for Anxiety and Depression (pre-post, group 
comparisons). 
Fig. 3. Sequential meta-analyses of ACT for Anxiety (primary outcome, active control 
condition). 
Fig. 4: Sequential meta-analysis of ACT for Depression (pre-post primary outcome, group 
primary outcome, group active control comparisons).  
 
 
Table 1: Characteristics of studies included in the meta-analyses 
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Unipolar 
Depression 
+ 
Unemploy
ment and 
Sick Leave 
1 
individu
al + 5 
group 
sessions 
Kocovski 
et al., 2013 
Canada – 
Communit
y sample 
of Social 
Anxiety 
Disorder 
Recruitme
nt from 
Health 
Profession
als and via 
media 
137 
(137) 
Tx: 
34.9
4 
(12.5
2) 
63/74 White = 62%  
Asian= 20%  
Black= 3.6% 
Hispanic=3.6
% Other= 
10.9% 
College 
or 
universit
y = 
63.5% 
Some 
post 
secondar
y 
educatio
n = 
27.0% 
N/R = 
9.5% 
DSM-IV 
diagnosis 
of Social 
Anxiety 
Disorder, 
Generalize
d 
12x 
weekly 
2 hour 
individu
al 
sessions 
Alonso et 
al.,  2013 
Spain – 
selected 
clinical 
sample in 
nursing 
care 
homes 
Recruitme
nt from 
two 
selected 
nursing 
homes 
10 
(10) 
Tx: 
87 
(2.44
) 
2/8 N/R None = 
40% 
Primary 
= 50% 
Secondar
y = 20% 
Chronic 
musculosk
eletal pain 
of articular 
origin for 
>6 months  
10x 
twice 
weekly 
group 
sessions 
of 2 
hours 
per 
week.  
Lappala
inen et 
Finland – 
communit
y sample 
Self-
selecting 
via 
24 
(24) 
Tx:  
47.1 
years 
24/0 N/R Tx: Mean 
duration 
of 7.1 
“Exhaustio
n, stress 
symptoms, 
Integrat
ed 
progra
 22 
al., 
2013 
of males newspaper 
advert 
(SD 
4.72 
years  or sleeping 
problems”. 
m of 
web/m
obile 
apps, 
persona
l 
monitor
ing and 
softwar
e with 
3x 
group 
interve
ntion 
sessions 
McCracken 
et al., 2013 
UK – 
Communit
y sample 
with 
Chronic 
Pain 
Recruitme
nt from 
General 
Medical 
Practices  
73 
(58) 
58.0 
(12.8
) 
23/50 White British 
= 97.3% 
Mean = 
12.4 
years of 
educatio
n (SD 
=4.2) 
Persistent 
pain of 
longer 
than 3 
months’ 
duration 
with GP 
consulatio
ns, 
Distress/D
isability 
and use of 
Medication 
4x 
Group 
sessions
, each4 
hours 
long. 3x  
one 
week 
and a 
further 
session 
one 
week 
later. 
Clarke et 
al., 2014 
UK  - 
clinical 
sample of 
individuals 
with 
treatment 
resistant 
mental 
health 
problems 
Referrals 
from 
Specialist 
personality 
disorder 
clinic in a 
public 
health 
setting 
45 
(45) 
43.4
6 
(s.d. 
1⁄4 
12.3
5). 
20/41 N/R N/R Treatment 
resistance 
via > one 
previous 
8-session 
episode of 
psycholo- 
gical 
therapy 
16x 
weekly 
group 
sessions 
of 2 
hours 
duratio
n 
Livheim et 
al., 2014.  
Australia – 
communit
y sample 
of young 
people at 
school 
Referral 
via school 
counsellors 
51 
(51) 
14.6 
(1.03
) 
8/43 N/R N/A mild to 
moderate 
depressive 
symptoms 
8x 
weekly 
group 
interve
ntion 
sessions 
Tamann
aeifar et 
al., 
2014 
Iran – 
Clinical 
sample of 
women 
with 
depressive 
disorder 
Referral to 
University 
Clinic 
19 
(19) 
25.2 
(4.2) 
0/19 N/R Diploma 
= 58% 
Master = 
42%  
DSM-IV 
diagnosis 
of Major 
Depressive 
Disorder 
12x  
twice 
weekly 
group 
interve
ntion 
sessions 
Mojtaba
ie, et al., 
2014 
Iran  -
clinical 
sample of 
women 
with 
breast 
cancer 
Referrals 
from 
specialist 
clinic 
30 
(30) 
N/R 0/30 N/R N/R Depressive 
symptoms, 
no 
diagnostic 
or severity 
criteria 
8   
interve
ntion 
sessions 
of one 
hour 
duratio
n  
Kohtala 
et al., 
2015 
Finland – 
communit
y sample 
of 
individuals 
Self-
selecting 
via local 
media 
57 
(57) 
46.2 
(SD = 
11.9 
12/45 All caucasian Compreh
ensive 
school = 
9% 
Secondar
subjective 
depressive 
symptoms 
or 
depressed 
4x 
group 
interve
ntion 
sessions 
 23 
reporting 
depressive 
symptoms 
y school 
= 45% 
Higher 
educatio
n = 43% 
Other = 
3% 
mood of 1 
hour 
duratio
n 
Studies Measuring Anxiety as outcome of interest 
Zettle et 
al., 2003 
USA - 
College 
students 
Self 
selecting 
volunteers 
via flyers 
37 
(24) 
30.9 
(N/R
) 
7/30 White= 66.6% 
Black = 21 
%Hispanic 
=12.5% 
N/R Test 
anxiety 
6 
individu
al 
weekly 
sessions  
Brown et 
al., 2011 
USA - 
University 
students 
Self 
selecting 
volunteers 
from 
Psychology 
courses 
16 
(16) 
20.2 
(1.9) 
5/11 White =43.7% 
Asian/Pacific 
Islander =25% 
Black =6.2% 
Caribbean/Hai
tian= 6.2% 
Latino=6.2% 
Multiracial/ot
her= 12.5% 
N/R Test 
anxiety 
Single – 
2 hour 
group 
session 
Mo'Tamed
i et al., 
2012 
Iran – 
clinical 
sample of 
female 
patients 
with 
headache  
Self-
referral 
from 
women 
attending 
specialised 
headache 
clinic 
30 
(30) 
Tx: 
34.1
8 
(7.30
) 
0/30 N/R Tx 
Group:  
13.00 
(2.90) 
Internatio
nal 
Classificati
on of 
Headache 
Disorders 
diagnosis 
of primary 
chronic 
headache  
8x 
weekly 
group 
sessions  
Arch et al., 
2012 
USA – 
Clinical 
sample of 
Anxiety 
disorders 
Adult 
Outpatient
s recruited 
via media 
128 
(128) 
37.9
3 
(11.7
0) 
61/67 White =67.2% 
Asian 
American/Paci
fic Islander 
=8.0% African 
American/Blac
k =8.8% 
Hispanic/Latin
o=12.0% 
American 
Indian/Alaska
n Native= 
0.08% 
15.41 
(2.07) 
DSM-IV 
Diagnosis 
of Anxiety 
Disorder 
(Panic, 
Social 
Anxiety,  
Specific 
Phobia, 
OCD or 
GAD) 
12 
individu
al 
weekly 
1-hour 
sessions 
Zargar et 
al., 2012 
Iran - 
Clinical 
Sample of 
GAD 
Patients 
receiving 
treatment 
for GAD 
24 
(18) 
Tx: 
34.5 
(2.41
) 
0/24 N/R Guidance 
School = 
11.1% 
High 
School = 
77.8% 
Bachelor 
= 11.1% 
DSM-IV 
Diagnosis 
of  
Generalize
d Anxiety 
Disorder 
12 x 90 
minute 
sessions 
Craske et 
al., 2014 
USA – 
individuals 
with social 
phobia 
Referrals 
from 
local 
flyers, 
Internet 
and local 
newspap
er 
advertise
87/87 28.3
7 
(6.76
) 
47/87 White=50.57
% 
Hispanic/Latin
o=17.24% 
African 
American/Blac
k=2.30% 
Asian 
American/Paci
fic 
Islander=18.3
9% 
Mean no. 
of years= 
15.04 
(1.95) 
DSM-IV 
Diagnosis 
of  Social 
Anxiety 
Disorder 
12 
weekly 
sessions 
of 
individu
al 
interve
ntion 
 24 
ments, 
and 
referrals.  
 
Lanza et 
al., 2014 
Spain – 
Forensic 
population 
of women 
with 
substance 
misuse 
disorders 
Referrals 
from 
Prison 
Team 
50 
(50) 
Tx:   
31.1 
(6.4) 
0/31 N/R N/R DSM-IV 
diagnosis 
of 
substance 
misuse 
disorder 
16x 
weekly 
group 
sessions 
of 90 
minutes 
duratio
n 
Studies measuring both Depression and Anxiety as outcomes 
Gratz et al., 
2006 
USA – 
Clinical 
Sample of 
Females 
presenting 
with 
Borderline 
PD 
Patients 
referred 
from 
clinicians 
at 
psychiatric 
hospital, 
private 
practice 
and self-
referrals 
via advert  
22 
(22) 
33.3
2 
(9.98
) 
0/22 All White Some 
college 
=21% 
College 
Graduate
42% 
Graduate 
school=3
7% 
Meeting 5 
or more 
criteria for 
DSM-IV 
BPD + at 
least 1 
episode of 
DSH over 
previous 6 
months 
14x 
weekly 
group 
session 
Woods et 
al., 2006 
USA – 
Unclear 
sampling 
N/R 28 
(25) 
35.0 
(10.2
) 
3/25 Caucasian = 
96.4% 
African 
American = 
3.6% 
Mean 
years of 
educatio
n = 15.0 
(2.8) 
DSM-IV 
diagnostic 
criteria for 
Trichotillo
mania;  
10 x 
individu
al 
sessions 
across 
12 
weeks  
Forman et 
al., 2007 
USA – 
Clinical 
sample 
with 
“Distressin
g 
Symptoms
” 
Clients 
presenting 
to 
University 
Counsellin
g Center 
101 
(99) 
27.8
7 
(7.25
) 
20/81 Caucasian  
=64.4% Asian 
=10.9% Black 
=12.9% 
Latino=3.0%  
N/R DSM-IV 
diagnostic 
criteria for 
depressive
, anxiety or 
adjustmen
t disorders 
Mean of 
15.27 
individu
al 
sessions 
Roemer et 
al., 2008 
USA – 
clinical 
sample  
with 
Generalize
d Anxiety 
Disorder 
Clients 
seeking 
treatment 
at 
specialist 
centre for 
anxiety 
disorders 
31 
(31) 
33.5
9 
(11.7
4) 
9/22 White = 87% 
Latino/Latina 
= 6.5 
Black = 3.25% 
Asian =3.25%  
N/R DSM-IV 
Diagnosis 
of  
Generalize
d Anxiety 
Disorder 
4x 90 
minute 
individu
al 
sessions 
+ 12x 
individu
al 
weekly 
1-hour 
sessions 
Wicksell et 
al., 2008 
Sweden – 
Clinical 
sample of 
chronic 
pain and 
whiplash 
Self-
selecting 
via Patient 
Organisatio
n in one 
geographic
al area of 
Sweden  
22 
(20) 
Tx: 
48.2 
(7.8) 
5/16 N/R N/R Pain 
duration of 
>3 months 
10 
individu
al 
sessions 
over 8 
weeks 
Johnston 
et al., 2010 
New 
Zealand – 
Clinical 
sample 
Referral 
via contact 
with 
Clinical 
24 
(14) 
Medi
an 
age = 
43 
10/14 N/R N/R No 
severity 
criteria 
Self-
Help 
interve
ntion 
 25 
with 
chronic 
pain 
Psychology 
and Pain 
Clinics 
via 
book 
and 
workbo
ok 
Bohlmeijer 
et al., 2011 
Netherlan
ds – 
Clinical 
sample 
with 
depressive 
symptoms 
Self-
referral via 
targeted 
recruitmen
t from 
mental 
health 
institutions 
93(93
) 
49.0
2 
(10.7
0) 
17/76 White Dutch = 
85% 
Other = 8% 
N/R = 7% 
<13 
Years of 
educatio
n= 
26.9% 
 13-16 
Years of 
educatio
n = 
33.3% 
>16 
Years of 
educatio
n = 
39.8% 
Mild to 
moderate 
psychologi
cal distress 
8x 2-
hour 
group 
based 
interve
ntion.  
Fledderus 
et al., 2011 
Netherlan
ds – 
Communit
y sample 
with 
depressive 
symptoms 
Self-
referral via 
media 
adverts 
376 
(376) 
42 
(N/R
) 
113/26
3 
White Dutch = 
93% 
Other = 7%  
Low 
Level = 
1.5% 
Middle 
Level 
=12% 
High 
Level = 
86.5% 
 
Mild to 
moderat
e 
depressi
ve 
sympto
ms  
 
9-week 
protoco
l with 
Self-
help 
book + 
weekly 
email 
support 
with 
guided 
questio
ning 
Muto et al., 
2011 
USA – 
Japanese 
students 
studying at 
overseas 
University 
Self-
referral via 
flyers on 
campus 
and email 
to students 
70 23.6 
(N/R
) 
26/44 N/R N/R No 
severity 
criterion 
Self-
help 
workbo
ok 
complet
ed over 
8 
weeks. 
Thorsel et 
al., 2011 
Sweden – 
clinical 
sample of 
individuals 
with 
chronic 
pain 
Recruitme
nt from 
specialised 
pain clinic 
90(90
) 
46.0 
years 
(SD 
12.3) 
32/58 N/R N/R Chronic 
pain with 
no severity 
criterion 
1x 
initial 
individu
al face 
to face 
session; 
workbo
ok + 7 
weeks 
of 30 
minute 
phone 
support
;  1x 90 
minute 
conclud
ing face 
to face 
session 
Westin et 
al., 2011 
Sweden – 
Clinical 
sample of 
individuals 
with 
Recruited 
from 
audiology 
departmen
ts and self-
64 
(62) 
50.9 
years 
(SD=
12.9 
34/30 N/R N/R Tinnitus of 
duration of 
> 6 months 
Up to 
10x 
individu
al 
sessions
 26 
tinnitus referral via 
adverts 
, mean 
number 
of 
session 
= 8.38 
(1.56) 
Wetherell 
et al., 2011 
USA – 
communit
y sample 
with 
chronic 
pain 
Recruited 
via clinics, 
advertisem
ents, 
media, pain 
support 
groups, 
other 
studies,  
referrals 
from other 
participant
s  
114 
(114) 
54.9 
(12.5
) 
56/58 N/R 44.7% 
had at 
least a 
bachelor’
s degree 
Chronic 
non-
malignant 
pain > 6 
months 
duration, 
with 
significant 
severity 
and 
interferenc
e  
8x 
weekly 
group 
sessions 
Jeffcoat et 
al., 2012 
USA – 
sample of 
teachers 
and staff of 
educationa
l district 
Self-
referral 
after mail 
drop via 
staff 
support 
office 
236 
(186) 
N/R N/R N/R N/R No 
severity 
criterion 
Self-
help 
workbo
ok 
complet
ed over 
8 
weeks. 
Jensen et 
al., 2012 
Sweden – 
clinical 
sample of 
women 
with 
Fibromyal
gia 
Referral 
via 
Primary 
Care 
Physicians 
43 
(34) 
45.6 
years 
(SD 
6.4) 
0/43 N/R N/R Meeting  
1990 
American 
College of 
Rheumatol
ogy 
diagnostic 
criteria for 
fibromyalg
ia 
12 
weekly 
sessions 
(90 
minutes 
each), 
conduct
ed in 
groups 
of 6 
patients
. 
Morton et 
al., 2012 
Australia – 
clinical 
sample of 
individuals 
with 
Borderline 
PD  
Referrals 
from 
specialist 
public 
sector 
mental 
health 
service  
 
41 
(28) 
Tx: 
35.6 
(9.33
) 
3/38 N/R Did not 
complete 
high 
school = 
29% 
Complet
ed high 
school = 
34%Som
e 
tertiary/ 
has 
degree = 
37% 
Individu
als with 
4 or 
more of 
the 9 
criteria 
for 
DSM-IV 
diagnosi
s of 
BPD  
 
12x 2-
hour 
group 
interve
ntion 
sessions 
Buhrman 
et al., 2013 
Sweden – 
clinical 
sample of 
individuals 
with 
chronic 
pain 
Recruitme
nt from 
specialised 
pain clinic 
76 
(76) 
49.1 
(10.3
4)  
 
31/45 N/R Nine-
year 
compuls
ory 
school=9
.2% 
Upper 
secondar
y 
school=4
Functional 
impairmen
t caused by 
chronic 
pain with 
medical 
investigati
on in 
previous 
year. 
7 
section 
online 
treatme
nt 
progra
m with 
downlo
adable 
mp3 
 27 
7.4% 
Universit
y 
educatio
n= 
43.4% 
files.  
Mean 
number 
of 4.2 
(2.7) 
sections 
complet
ed 
Carlbring 
et al., 2013 
Sweden – 
communit
y sample 
of 
individuals 
reporting 
as 
depressed 
Recruitme
nt via 
newspaper 
advert 
80 
(80) 
44.4 
(13.5
) 
14/66 N/R Element
ary 
school= 
3.8% 
Upper 
secondar
y school 
= 16.3% 
Vocation
al 
training 
= 3.8% 
Universit
y 
(ongoing
) =12.5% 
Universit
y 
(complet
ed)= 
63.8% 
Symptoms 
of mild to 
moderate 
depression 
on 
MADRS-S 
 Module 
internet
-based 
treatme
nt 
progra
mme + 
15 
minutes 
per 
week 
acces to 
internet 
therapis
t 
Levin et 
al., 2014 
USA – 
Undergrad
uate 
college 
students 
Self-
selecting 
via campus 
and local 
adverts 
76(76
) 
18.3
7 
(.54) 
35/41 Caucasian 
=71.1%  
African 
American 
=7.9%  
Asian =9.2% 
Latino/Hispan
ic =15.8% 
Native 
American=9.2
% 
Pacific 
Islander/Haw
aiian = 2.6% 
N/R No 
severity 
criterion 
2x web 
based 
multime
dia 
lessons 
with 
tailored 
emails  
Avdagic et 
al., 2014 
Australia – 
individuals 
presenting 
with GAD 
Self-
selecting 
via campus 
and local 
adverts 
51 
(51) 
36.1
7 
(13.1
) 
17/34 N/R N/R DSM-IV 
Diagnosis 
of  
Generalize
d Anxiety 
Disorder 
6x 
weekly 
group 
sessions 
of 2 
hours 
duratio
n 
Livheim et 
al., 2014. 
Sweden  -
communit
y sample 
of young 
people at 
school 
Self-
selecting 
sample  
scoring 
above the 
80th 
percentile 
SDQ, PSS 
and GHQ-
12 at 
screening.  
32 
(32) 
14-
15 
years 
9/22 N/R N/A As for 
recruitmen
but not 
severe 
problems 
or suicidal 
ideation 
6x 90 
minute 
weekly 
group 
interve
ntion 
sessions 
Yadavaia 
et al., 2014 
USA - 
Undergrad
uate 
Self-
selecting 
sample of 
78 
(73) 
19.6
9 
(2.66
19/54 Asian/Pacific 
Islander=16% 
African-
N/R GHQ-10 
score of 
<10. 
1x 6 
hour 
worksh
 28 
 
 
 
 
 
Notes: N/R = Not Reported; N/A = Not Applicable; Tx = Treatment Group; DAWBA = Development and Wellbeing Assessment (Goodman et 
al. 2000); UK = United Kingdom; USA = United States of America; GAD = Generalized Anxiety Disorder; OCD = Obsessive Compulsive 
Disorder;  SDQ = Strengths and Difficulties Questionnaire; PSS = Perceived Stress Scale; GHQ-12 = General Health Questionnaire – 12 item;  
 
 
Table 2. Measurement characteristics of ACT studies included in the meta-analysis for 
anxiety.   
Study 
Reference 
Post Treatment 
Group 
Comparison Outcom
e 
measur
e 
Contr
ol 
condi
tion 
Cont
rol  
grou
p 
Outcome  
category N (Tx) 
N 
(Contro
l) 
Zettle et al., 
2003 12 12 STAI 
Activ
e SysD Primary 
Gratz et al., 
2006 12 10 DASS-A 
Passi
ve WL 
No 
Differentiat
ion 
Woodset al., 
2006 12 13 PAI-A 
Passi
ve WL 
No 
Differentiat
ion 
Forman et al., 
2007 55 44 BAI 
Activ
e CT 
No 
Differentiat
ion 
Roemer et al., 
2008 15 16 DASS-A 
Passi
ve WL Primary 
Wicksell et al., 
2008 11 10 HADS-A 
Passi
ve WL Secondary 
Johnston et al., 
2010 6 8 BAI 
Passi
ve WL 
No 
Differentiat
ion 
Bohlmeijer et 
al., 2011 49 44 HADS-A 
Passi
ve WL  Secondary 
Brown et al., 
2011 6 6 STAI 
Activ
e CT 
No 
Differentiat
ion 
Fledderus et 
al., 2011 125 126 HADS-A 
Passi
ve WL Secondary 
Muto et al., 
2011 30 31 DASS-A 
Passi
ve WL Secondary 
college 
students 
psychology 
undergrad
uates 
meeting 
screening 
criteria 
0 American/Blac
k=7% 
Hispanic/Latin
o=12% 
Native 
American=1% 
White/Non-
Hispanic=74% 
op 
 29 
Thorsell et al., 
2011 28 27 HADS-A 
Activ
e AR 
No 
Differentiat
ion 
Westin et al., 
2011 21 21 HADS-A 
Activ
e TRT Secondary 
Wetherell et 
al., 2011 49 50 PASS 
Activ
e CBT 
No 
Differentiat
ion 
Arch et al., 
2012 71 57 PSWQ 
Activ
e CBT Primary 
Jeffcoat et al., 
2012 39 42 DASS-A 
Passi
ve WL Secondary 
Jensen et al., 
2012 19 15 STAI 
Passi
ve WL Secondary 
Mo'Tamedi et 
al., 2012 11 15 STAI-T 
Passi
ve WL 
No 
Differentiat
ion 
Morton et al., 
2012 14 14 DASS-A 
Passi
ve WL Secondary 
Zargar et al., 
2012 9 9 PSWQ 
Passi
ve WL 
No 
Differentiat
ion 
Buhrman et 
al., 2013 29 32 HADS-A 
Passi
ve WL Secondary 
Carlbring et 
al., 2013 40 38 BAI 
Passi
ve WL 
No 
Differentiat
ion 
Craske et al., 2014 33 29 CSR 
Activ
e CBT Primary 
Lanza et al., 2014 
18 19 ASI 
Activ
e CBT 
No 
Differentiat
ion 
Levin et al., 2014 
37 39 DASS-A 
Passi
ve WL 
No 
Differentiat
ion 
Avdagic et al., 2014 
19 19 DASS-A 
Activ
e CBT Secondary 
Livheim et al., 2014 
Swedish Sample. 
15 15 DASS-A 
Passi
ve TAU Primary 
Yadavaia et al., 
2014 
43 39 DASS-A Passi
ve 
WL No 
Differentiat
ion 
Note. Outcome measure abbreviations: STAI – State Trait Anxiety Inventory, DASS – 
Depression Anxiety Stress Scale, PAI-A - Personality Assessment Inventory Anxiety, BAI – 
Beck Anxiety Inventory, HADS – Hospital Anxiety and Depression Scale, PASS – Pain Anxiety 
Symptom Scale, PSWQ – Penn State Worry Scale, AS - Control condition abbreviations: SysD 
– Systematic Desensitization, WL –  
 30 
Waiting List, CT – Cognitive Therapy, AR – Applied Relaxation, TRT – Tinitus Retraining 
Therapy, CSR = Clinical Severity Rating; ASI = Anxiety Sensitivity Inventory .  
Table 3. Measurement characteristics of ACT studies included in the meta-analysis for 
depression. 
 
Study 
Reference 
Post Treatment 
Group Comparison 
Outcome  
measure 
Cont
rol  
cond
ition 
Con
trol  
gro
up 
Outcome  
category N (Tx) 
N 
(Control
) 
Zettle & Rains 
1989 11 10 BDI 
Activ
e CT Primary 
Bond et al., 
2000 24 21 BDI 
Activ
e IPP 
No 
Differentia
tion 
Hayes et al., 
2004 42 42 BDI 
Activ
e 
ITS
F Secondary 
Gratz et al., 
2006 12 10 DASS-D 
Passi
ve WL 
No 
Differentia
tion 
Woods et al., 
2006 12 12 PAI-D 
Passi
ve WL 
No 
Differentia
tion 
Forman et al., 
2007 55 44 BDI 
Activ
e CT 
No 
Differentia
tion 
Lappalainen et 
al., 2007 14 14 BDI 
Activ
e 
CB
T Secondary 
Roemer et al., 
2008 15 16 BDI 
Passi
ve WL Secondary 
Wicksell et al., 
2008 11 11 HADS-D 
Passi
ve WL Secondary 
Wicksell et al., 
2009 15 14 CES-DC 
Activ
e 
MD
T Secondary 
Hinton et al., 
2010 10 12 BDI 
Passi
ve WL Primary 
Johnston et al., 
2010 6 8 CMDI 
Passi
ve WL 
No 
Differentia
tion 
Smout et al., 
2010 14 17 BDI 
Activ
e 
CB
T Secondary 
Twohig et al., 
2010 36 32 BDI 
Activ
e 
PR
T Secondary 
Bohlmeijer et 
al., 2011 49 44 CES-D 
Passi
ve WL  Primary 
Fledderus et 
al., 2011 125 126 CES-D 
Passi
ve WL  Primary 
Hayes et al., 19 11 RADS-2 Passi WL  No 
 31 
2011 ve Differentia
tion 
Muto et al., 
2011 30 31 DASS-D 
Passi
ve WL Secondary 
Thorsel et al., 
2011 28 29 HADS-D 
Activ
e AR 
No 
Differentia
tion 
Westin et al., 
2011 21 18 HADS-D 
Activ
e 
TR
T Secondary 
Wetherell et al., 
2011 49 50 BDI 
Activ
e 
CB
T 
No 
Differentia
tion 
Folke et al., 
2012 14 13 BDI 
Passi
ve WL Primary 
Jeffcoat et al., 
2012 45 44 DASS-D 
Passi
ve WL  Secondary 
Jensen et al., 
2012 20 16 BDI 
Passi
ve WL Secondary 
Morton et al., 
2012 14 14 DASS-D 
Passi
ve WL Secondary 
Buhrman et al., 
2013 29 32 HADS-D 
Passi
ve WL Secondary 
Carlbring et al., 
2013 40 38 BDI 
Passi
ve WL 
No 
Differentia
tion 
Kocovski et al., 
2013 37 32 BDI 
Activ
e 
CB
GT Tertiary 
McCracken et 
al., 2013 31 27 PHQ-9 
Passi
ve WL Primary 
Alonso et al.,  2013 
5 5 GDS-10 
Passi
ve WL Secondary 
Lappalainen et 
al., 2013 11 12 BDI 
Passi
ve WL Primary 
Clarke et al., 2014 
24 15 BDI 
Activ
e 
CB
T Primary 
Livheim et al., 2014. 
Australia Sample 
32 19 RADS-2 
Passi
ve 
TA
U Primary 
Livheim et al., 2014 
Swedish Sample 
15 17 DASS-D 
Passi
ve 
TA
U Primary 
Tamannaeifar 
et al., 2014 10 9 BDI 
Activ
e 
CB
T Primary 
Levin et al., 2014 
37 39 DASS-D 
Passi
ve WL 
No 
Differentia
tion 
Avdagic et al., 2014 
19 19 DASS_D 
Activ
e 
CB
T Secondary 
Yadavaia et al., 2014 
28 39 DASS-D 
Passi
ve WL 
No 
Differentia
 32 
tion 
Kohtala et al., 2015 
28 29 BDI 
Passi
ve WL Primary 
Note. Outcome measure abbreviations: BDI – Beck Depression Inventory, PAI-D – 
Personality Assessment Inventory Depression, HADS – Hospital Anxiety and 
Depression Scale, CES-CD - Center for Epidemiological Studies Depression Scale for 
Children, CES-D - Center for Epidemiological Studies Depression Scale, RADS-2 – 
Reynolds Adolescent Depression Scale 2, DASS – Depression Anxiety Stress Scale, PHQ9 
– Patient Health Questionnaire 9 Control condition abbreviations: CT – Cognitive 
Therapy, IPP – Innovation Promotion Programme, ITSF – Intensive Twelve Steps 
Facilitation, WL – Waiting List, CBT – Cognitive Behavioural Therapy, MDT – 
Multidisciplinary Treatment Approach, PRT – Progressive Relaxation Training, AR – 
Applied Relaxation, TRT - , CBGT – Cognitive Behavioural Group Therapy, GDS-10 = 
Geriatric Depression Scale; . 
Table 4. Cumulative meta-analyses of ACT for Anxiety and Depression.  
` k HO
IS 
At final interim analysis  Bound
ary 
crosse
d 
Sufficie
ncy  
Additio
nal 
sample 
requir
ed  (n) 
Primary Analysis   N t d 95
% 
CI 
I2     
Anxiety/P 2
8 
220 81
8 
> 
1 
.95**
* 
0.5
5-
1.3
6 
86.1 Y Y 0 
Anxiety/G 2
8 
848 16
28 
> 
1 
.45* 0.1
9-
0.6
4 
84.1 N Y 0 
Depression/P 3
9 
220 10
37 
> 
1 
.92**
* 
0.6
4-
1.1
9 
82.7 N Y 0 
Depression/G 3
9 
848 19
87 
> 
1 
.54**
* 
0.3
4-
0.7
3 
80.6 Y Y 0 
           
Secondary 
Analysis 
          
Anxiety/P/Prim
ary 
5 220 14
6 
.8
4 
1.85
** 
0.0
5-
36
4 
93.3 N N 74 
Anxiety/G/Prim
ary 
5 848 27
5 
.4
3 
.77 -
2.3
8-
93.7 N N 573 
 33 
0.8
5 
Anxiety/G/Acti
ve 
1
0 
848 55
8 
.8
3 
-.04 -
0.2
1-
0.1
4 
5.3 N N 290 
Depression/P/P
rimary 
1
2 
220 36
0 
> 
1 
1.22
*** 
0.7
4-
1.7
1 
74.6 Y Y 0 
Depression/G/P
rimary 
1
2 
848 67
4 
.7
1 
.73** 0.3
0-
1.1
6 
63.9 Y Y 0 
Depression/G/
Active 
1
5 
848 75
5 
> 
1 
.26 -
0.0
6-
0.5
9 
73.3 N N 93 
Note. /P – pre post comparison; /G – group comparison; /Primary – Primary 
target outcome; Active – Active control condition; k - number of studies; HOIS - 
Heterogeneity Adjusted Optimal Information Size; d- Pooled effect size; 95%CI - 
95% Confidence Interval; I2- I-squared value. As described above I2 is defined as 
the ration between difference of Q and the degree of freedom by Q.  
* p < .05  
** p < .01 
*** p < .001 
Highlights 
 
• ACT is an efficacious treatment for anxiety or depression. 
• Evidence is currently insufficient to conclude that ACT is more effective than 
CBT. 
• We report sample size estimates where sufficiency criteria have not been met. 
• Use of Cumulative and Sequential Meta Analysis can increase confidence in the 
conclusions of quantitative reviews. 
 
 
Figure 1: Flow diagram of the study selection process. 
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Figure 2: Sequential meta-analyses of ACT for Anxiety and Depression (pre-post, 
group comparisons). 
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Fig. 3. Sequential meta-analyses of ACT for Anxiety (primary outcome, active 
control condition). 
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Fig. 4: Sequential meta-analysis of ACT for Depression (pre-post primary 
outcome, group primary outcome, group active control comparisons).  
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